HealthEquity (HealthEquity) ROCE % : 5.74% (As of Jan. 2024)

View and export this data going back to 2014. Start your Free Trial

What is HealthEquity ROCE %?

ROCE % measures how well a company generates profits from its capital. It is calculated as EBIT divided by Capital Employed, where Capital Employed is calculated as Total Assets minus Total Current Liabilities. HealthEquity's annualized ROCE % for the quarter that ended in Jan. 2024 was 5.74%.

HealthEquity ROCE % Historical Data

The historical data trend for HealthEquity's ROCE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

HealthEquity ROCE % Chart

HealthEquity Annual Data

Trend

Jan15

Jan16

Jan17

Jan18

Jan19

Jan20

Jan21

Jan22

Jan23

Jan24

ROCE %

Get a 7-Day Free Trial

4.69

1.59

-1.11

0.35

4.35

HealthEquity Quarterly Data
	Apr19	Jul19	Oct19	Jan20	Apr20	Jul20	Oct20	Jan21	Apr21	Jul21	Oct21	Jan22	Apr22	Jul22	Oct22	Jan23	Apr23	Jul23	Oct23	Jan24
ROCE %	Get a 7-Day Free Trial															1.94	3.39	3.72	4.65	5.74

HealthEquity ROCE % Calculation

HealthEquity's annualized ROCE % for the fiscal year that ended in Jan. 2024 is calculated as:

ROCE %	=	EBIT	/	( (Capital Employed	+	Capital Employed)	/ count )
		(A: Jan. 2024 )		(A: Jan. 2023 )		(A: Jan. 2024 )
	=	EBIT	/	( ( (Total Assets - Total Current Liabilities)	+	(Total Assets - Total Current Liabilities) )	/ count )
		(A: Jan. 2024 )		(A: Jan. 2023 )		(A: Jan. 2024 )
	=	130.495	/	( ( (3088.9 - 131.061)	+	(3163.79 - 117.091) )	/ 2 )
	=	130.495	/	( (2957.839	+	3046.699)	/ 2 )
	=	130.495	/	3002.269
	=	4.35 %

HealthEquity's ROCE % of for the quarter that ended in Jan. 2024 is calculated as:

ROCE %	=	EBIT ⁽¹⁾	/	( (Capital Employed	+	Capital Employed)	/ count )
		(Q: Jan. 2024 )		(Q: Oct. 2023 )		(Q: Jan. 2024 )
	=	EBIT	/	( ( (Total Assets - Total Current Liabilities)	+	(Total Assets - Total Current Liabilities) )	/ count )
		(Q: Jan. 2024 )		(Q: Oct. 2023 )		(Q: Jan. 2024 )
	=	173.432	/	( ( (3093.502 - 96.236)	+	(3163.79 - 117.091) )	/ 2 )
	=	173.432	/	( ( 2997.266	+	3046.699 )	/ 2 )
	=	173.432	/	3021.9825
	=	5.74 %

(1) Note: The EBIT data used here is four times the quarterly (Jan. 2024) EBIT data.

HealthEquity (NAS:HQY) ROCE % Explanation

ROCE % can be especially useful when comparing the performance of capital-intensive companies. Unlike ROE %, which indicates the profitability of Shareholders Equity, ROCE % also considers long-term debt in Capital Employed. This can be helpful when analyzing companies with significant debt, as the result is neutralized by taking debt into consideration.

Generally speaking, a higher ROCE % indicates a stonger profitability for a company. Moreover, it is important to look at the ratio from a long term perspective. Investors tend to favor companies with stable and rising ROCE % trend over those with volatile ones.

HealthEquity ROCE % Related Terms

Thank you for viewing the detailed overview of HealthEquity's ROCE % provided by GuruFocus.com. Please click on the following links to see related term pages.

HealthEquity (HealthEquity) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » HealthEquity Inc (NAS:HQY) » Definitions » ROCE %

Comparable Companies

Traded in Other Exchanges

2HE:Germany 2HE:Germany

Address

15 West Scenic Pointe Drive, Suite 100, Draper, UT, USA, 84020

Website

https://www.healthequity.com

HealthEquity Inc provides solutions that allow consumers to make healthcare saving and spending decisions. Its technology allows customers to see their tax-advantaged healthcare savings, compare treatment options and pricing, pay healthcare bills, receive benefit information, and earn wellness incentives. The firm primarily partners with health plans and employers and serves as the custodian of its customers' health savings accounts (HSAs). HealthEquity also engages in reimbursement arrangements and offers healthcare incentives to its members. In addition, the company provides investment advisory services to customers whose account balances exceed a certain threshold. HealthEquity generates its revenue in the United States.

Executives

Delano Ladd	officer: Executive VP, GC & Corp. Secy.	15W. SCENIC POINTE DR., SUITE 100, DRAPER UT 84020
Ian Sacks	director	TOWERBROOK CAP., PARK AVENUE TOWER, 65 E 55TH ST., 27TH FLOOR, NEW YORK NY 10022
Elimelech Rosner	officer: EVP, Chief Technology Officer	5196 BELMORE COURT, SUWANEE GA 30024
Stephen Neeleman	director, officer: Founder and Vice Chairman	15 W. SCENIC POINTE DR., STE. 100, DRAPER UT 84020
Tyson D. Murdock	officer: EVP & CFO	2275 S. 2200 E., SALT LAKE CITY UT 84109
Jon Kessler	director, officer: President and CEO	15 W. SCENIC POINTE DR., STE. 100, DRAPER UT 84020
Frank Corvino	director	GREENWICH HOSPITAL, 5 PERRYRIDGE ROAD, GREENWICH CT 06830
Larry L Trittschuh	officer: EVP Chief Security Officer	1051 RUNNYMEDE ROAD, OAKWOOD OH 45419
James M Lucania	officer: EVP & CFO	101 WOLF DRIVE, THOROFARE NJ 08086
Gayle Furgurson Wellborn	director	123 TORRENCE CHAPEL ROAD, MOORESVILLE NC 28117
Debra Charlotte Mccowan	director	1436 CABRILLO AVENUE, BURLINGAME CA 94010
Paul Black	director	400 WOOD ROAD, BRAINTREE MA 02184
Edward Bloomberg	officer: Chief Operating Officer	13207 WINDSOR STREET, LEAWOOD KS 66209
Rajesh Natarajan	director	7500 DALLAS PARKWAY, SUITE 700, PLANO TX 75024
Evelyn S Dilsaver	director	C/O LONGS DRUG STORES CORPORATION, 141 NORTH CIVIC DRIVE, WALNUT CREEK CA 94596